Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update

Expert Opin Emerg Drugs. 2024 Sep;29(3):187-192. doi: 10.1080/14728214.2024.2341878. Epub 2024 Apr 15.

Authors

Jonathan A Fallowfield¹, Maria Jimenez Ramos¹

Affiliation

¹ Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.

PMID: 38603460
DOI: 10.1080/14728214.2024.2341878

No abstract available

Keywords: compensated cirrhosis; decompensated cirrhosis; liver cirrhosis; metabolic dysfunction-associated steatohepatitis; synthetic drugs.

Publication types

Editorial

MeSH terms

Animals
Antifibrotic Agents / pharmacology
Drug Design
Drug Development*
Humans
Liver Cirrhosis* / drug therapy
Synthetic Drugs / pharmacology

Substances

Synthetic Drugs
Antifibrotic Agents